← 產業報告目錄
Topical Drug Delivery Market Size, Share & Trends Analysis Report By Type (Semi-solids (Creams, Gels, Lotions), Solids (Suppositories), Liquids (Solutions), Transdermal Products), Route (Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres), Region And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-12頁數 180報告編號 INSIGHTACE-6b8f2f15fa
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Topical Drug Delivery Market stood at USD 208.25 billion in 2022, and is projected to reach USD 418.70 billion by 2031, recording a CAGR of 8.1% from 2023 through 2031.
Topical Drug Delivery covers key industry insights & findings from the report:
The main reasons driving this market's growth constitute the rising rates of minor illnesses like acne and psoriasrepresents as well as skin diseases like eczema. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Topical Drug Delivery Market Snapshot
Chapter 4. Global Topical Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product:
5.2.1. Semi-Solid Formulations
5.2.1.1. Creams
5.2.1.2. Ointments
5.2.1.3. Lotions
5.2.1.4. Gel
5.2.1.5. Pastes
5.2.2. Liquid Formulations
5.2.2.1. Suspensions
5.2.2.2. Solutions
5.2.3. Solid Formulations
5.2.3.1. Powders
5.2.3.2. Suppositories
5.2.4. Transdermal Products
5.2.4.1. Transdermal Patches
5.2.4.2. Transdermal Semi-Solids
Chapter 6. Market Segmentation 2: By Route of Administration Estimates & Trend Analysis
6.1. By Route of Administration & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Route of Administration:
6.2.1. Dermal Drug Delivery
6.2.2. Ophthalmic Drug Delivery
6.2.3. Rectal Drug Delivery
6.2.4. Vaginal Drug Delivery
6.2.5. Nasal Drug Delivery
Chapter 7. Market Segmentation 3: By Facility of Use Estimates & Trend Analysis
7.1. By Facility of Use & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Facility of Use:
7.2.1. Home Care Settings
7.2.2. Hospitals & Clinics
7.2.3. Burn Centers
7.2.4. Other Facilities
Chapter 8. Topical Drug Delivery Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031
8.1.2. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2019-2031
8.1.3. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Facility of Use, 2019-2031
8.1.4. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Topical Drug Delivery Market revenue (US$ Million) By Product, 2019-2031
8.2.2. Europe Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, 2019-2031
8.2.3. Europe Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, 2019-2031
8.2.4. Europe Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Product, 2019-2031
8.3.2. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, 2019-2031
8.3.3. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, 2019-2031
8.3.4. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Topical Drug Delivery Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.4.2. Latin America Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
8.4.3. Latin America Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, (US$ Million) 2019-2031
8.4.4. Latin America Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 3M
9.2.2. AbbVie Inc.
9.2.3. Bausch Health Companies Inc.
9.2.4. Bayer AG
9.2.5. Boehringer Ingelheim International GmBH
9.2.6. Bristol Myers Squibb
9.2.7. Cipla
9.2.8. CMP Pharma, Inc.
9.2.9. Crescita Therpeautics Inc.
9.2.10. Encore Dermatology, Inc.
9.2.11. Galderma
9.2.12. GlaxoSmithKline Plc.
9.2.13. Glenmark Pharmaceuticals Ltd.
9.2.14. Hisamitsu Pharmaceuticals Inc.
9.2.15. Johnson & Johnson Private Limited
9.2.16. Lavipharm
9.2.17. Lead Chemical Co., Ltd.
9.2.18. Merck & Co.Inc..
9.2.19. Novartis International AG
9.2.20. Pfizer Inc.
9.2.21. Prosolus Inc.
9.2.22. Purdue Pharma L.P.
9.2.23. Rusan Pharma Ltd.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們